Rana P, Deshmukh H, Shah U, Kumar V, Kanungo S, Singhal D
Clin Ophthalmol. 2024; 18:3071-3081.
PMID: 39493839
PMC: 11531239.
DOI: 10.2147/OPTH.S488866.
Chen Y, Han X, Gordon I, Safi S, Lingham G, Evans J
J Glob Health. 2022; 12:04026.
PMID: 35356661
PMC: 8939288.
DOI: 10.7189/jogh.12.04026.
Stattin M, Haas A, Ahmed D, Graf A, Krepler K, Ansari-Shahrezaei S
Eur J Ophthalmol. 2021; 32(4):2312-2318.
PMID: 34726553
PMC: 9294617.
DOI: 10.1177/11206721211052389.
Kodjikian L, Parravano M, Clemens A, Dolz-Marco R, Holz F, Munk M
Eye (Lond). 2021; 35(8):2119-2135.
PMID: 33795837
PMC: 8302650.
DOI: 10.1038/s41433-021-01487-0.
Garcia-Layana A, Figueroa M, Arias L, Araiz J, Ruiz-Moreno J, Garcia-Arumi J
J Ophthalmol. 2015; 2015:412903.
PMID: 26491550
PMC: 4600506.
DOI: 10.1155/2015/412903.
Defining response to anti-VEGF therapies in neovascular AMD.
Amoaku W, Chakravarthy U, Gale R, Gavin M, Ghanchi F, Gibson J
Eye (Lond). 2015; 29(6):721-31.
PMID: 25882328
PMC: 4469673.
DOI: 10.1038/eye.2015.48.
A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.
Garcia-Layana A, Arias L, Figueroa M, Araiz J, Ruiz-Moreno J, Garcia-Arumi J
J Ophthalmol. 2015; 2014:595132.
PMID: 25587438
PMC: 4283441.
DOI: 10.1155/2014/595132.
Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration.
Chen Y, Han F
Ther Clin Risk Manag. 2012; 8:343-51.
PMID: 22911433
PMC: 3404592.
DOI: 10.2147/TCRM.S32801.
Management of neovascular age-related macular degeneration in clinical practice: initiation, maintenance, and discontinuation of therapy.
Keane P, Tufail A, Patel P
J Ophthalmol. 2011; 2011:752543.
PMID: 22174995
PMC: 3228281.
DOI: 10.1155/2011/752543.
Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration.
Mathew R, Sivaprasad S
Eye (Lond). 2011; 26(3):389-93.
PMID: 22173073
PMC: 3298986.
DOI: 10.1038/eye.2011.326.
[Differences in the treatment of exudative age-related macular degeneration in Germany and Great Britain].
Heimann H, Yang Y, Wachtlin J, Pauleikhoff D
Ophthalmologe. 2011; 108(6):575-84.
PMID: 21695609
DOI: 10.1007/s00347-011-2383-0.
A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications.
Kelly S, Barua A
Eye (Lond). 2011; 25(6):710-6.
PMID: 21527957
PMC: 3178143.
DOI: 10.1038/eye.2011.89.
Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab.
Sandhu S, Manvikar S, Steel D
Clin Ophthalmol. 2010; 4:637-42.
PMID: 20668667
PMC: 2909894.
DOI: 10.2147/opth.s10060.
